In women without diabetes, insulin effectively reduces ACS-induced hyperglycemia after betamethasone administration; however, the impact on neonatal outcomes has not been assessed.6 Although antenatal betamethasone is known to induce both maternal hyperglycemia and neonatal hypoglycemia, current evidence is insufficient to determine whether treating maternal hyperglycemia reduces the risk of neonatal hypoglycemia, particularly in preterm infants. Here, INS is linked to Hyperglycemia.